Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Androgen receptor inhibitor

DRUG CLASS:

Androgen receptor inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	enzalutamide Sensitive: A1 - Approval enzalutamide Sensitive : A1	enzalutamide Sensitive: A1 - Approval enzalutamide Sensitive : A1
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	darolutamide Sensitive: A1 - Approval darolutamide Sensitive : A1	darolutamide Sensitive: A1 - Approval darolutamide Sensitive : A1
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	goserelin acetate + flutamide Sensitive: A1 - Approval goserelin acetate + flutamide Sensitive : A1	goserelin acetate + flutamide Sensitive: A1 - Approval goserelin acetate + flutamide Sensitive : A1
HRD	Prostate Cancer	HRD	Prostate Cancer	talazoparib + enzalutamide Sensitive: A1 - Approval talazoparib + enzalutamide Sensitive : A1	talazoparib + enzalutamide Sensitive: A1 - Approval talazoparib + enzalutamide Sensitive : A1
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	enzalutamide Resistant: A2 - Guideline enzalutamide Resistant : A2	enzalutamide Resistant: A2 - Guideline enzalutamide Resistant : A2
AR positive	Salivary Gland Cancer	AR positive	Salivary Gland Cancer	bicalutamide Sensitive: A2 - Guideline bicalutamide Sensitive : A2	bicalutamide Sensitive: A2 - Guideline bicalutamide Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	bicalutamide + goserelin acetate Sensitive: A2 - Guideline bicalutamide + goserelin acetate Sensitive : A2	bicalutamide + goserelin acetate Sensitive: A2 - Guideline bicalutamide + goserelin acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	bicalutamide + triptorelin Sensitive: A2 - Guideline bicalutamide + triptorelin Sensitive : A2	bicalutamide + triptorelin Sensitive: A2 - Guideline bicalutamide + triptorelin Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	triptorelin + flutamide Sensitive: A2 - Guideline triptorelin + flutamide Sensitive : A2	triptorelin + flutamide Sensitive: A2 - Guideline triptorelin + flutamide Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	leuprolide acetate + bicalutamide Sensitive: A2 - Guideline leuprolide acetate + bicalutamide Sensitive : A2	leuprolide acetate + bicalutamide Sensitive: A2 - Guideline leuprolide acetate + bicalutamide Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	leuprolide acetate + flutamide Sensitive: A2 - Guideline leuprolide acetate + flutamide Sensitive : A2	leuprolide acetate + flutamide Sensitive: A2 - Guideline leuprolide acetate + flutamide Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	bicalutamide + histrelin acetate Sensitive: A2 - Guideline bicalutamide + histrelin acetate Sensitive : A2	bicalutamide + histrelin acetate Sensitive: A2 - Guideline bicalutamide + histrelin acetate Sensitive : A2